Wednesday, 25 September 2013

Purdue Pharma L.P. Receives FDA Approval For 15 mcg/hour Dosage Strength Of Butrans (buprenorphine) Transdermal System CIII « New Drug Approvals

Purdue Pharma L.P. Receives FDA Approval For 15 mcg/hour Dosage Strength Of Butrans (buprenorphine) Transdermal System CIII « New Drug Approvals:

'via Blog this'
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)